vimarsana.com

Page 123 - அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New recommendations aim to eliminate racial bias in myeloma trials

Cancer & COVID Vax Priority; AML/MDS Halt Sickle Cell Trial; How a Dog s Nose Knows

email article The American Association for Cancer Research as well as other leading organizations and cancer centers 130 in all are urging the Biden administration and public health departments to prioritize cancer patients for access to COVID-19 vaccines due to their risk of severe illness. More and more research on COVID-19 and cancer points to hematologic malignancies presenting the greatest risk. ( The Scientist) Bluebird Bio temporarily halted clinical trials of its investigational gene therapy for sickle cell disease after two participants were diagnosed with acute myeloid leukemia and myelodysplastic syndrome. The phase III OlympiA trial met its primary endpoint, with adjuvant olaparib (Lynparza) improving invasive disease-free survival in early breast cancer patients with high-risk,

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.